| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |